Citing lack of benefit, NIH halts trial of hydroxychloroquine for COVID-19
(HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long supported by President Donald Trump as a possible panacea for COVID-19.
Jun 22, 2020
0
2